Status:
COMPLETED
PRP vs PRP Plus IGF for Patellar Tendinosis
Lead Sponsor:
Ohio State University
Conditions:
Tendinopathy
Patellar Ligament
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis. Aim: To perform a randomized, double blinded study comparing the clinical effect o...
Detailed Description
Introduction/Background: Patellar tendinosis is a frustrating ailment commonly encountered in sports medicine. Treating this condition continues to be a significant challenge for sports medicine phys...
Eligibility Criteria
Inclusion
- \>6 weeks of symptomatic patellar tendinosis
- unilateral or bilateral
- 18 yrs of age or older
- active in sport and exercise at least 3x / week
- able to take time away from sport (for healing and rehabilitation phase after procedure)
- failed at least 6 weeks of guided rehabilitation (under the supervision of either a certified athletic trainer or physical therapist)
- minimum Tegner activity level of 4
Exclusion
- Steroid injection in target knee in the last 3 months
- PRP in the target knee in the last 6 months
- No other cellular treatments in index knee (bone marrow, amniotic suspensions) last 1 year
- Participation in any experimental device or drug study within 1 year before screening visit
- Oral or IM steroids for last 3 months
- Dry needling of patellar tendon in last 6 months
Key Trial Info
Start Date :
February 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 16 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04350827
Start Date
February 25 2020
End Date
October 16 2021
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Sports Medicine Center
Columbus, Ohio, United States, 43221